Preview

Rational Pharmacotherapy in Cardiology

Advanced search

INFLUENCE OF BRONCHOLYTIC THERAPY ON VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

https://doi.org/10.20996/1819-6446-2009-5-5-63-66

Abstract

Aim. To evaluate effects of broncholytic therapy on ventricular rhythm disorders and high resolution electrocardiogram indices in patients with chronic obstructive pulmonary disease (COPD).

Material and methods. 144 patients (54 women and 90 men; aged 47,1±1,5 y.o.) with COPD and 35 patients of control group without respiratory and cardiovascular diseases (23 men and 12 women; aged 42,4±2,8 y.o.) were examined. 24-hour ECG monitoring and high resolution ECG with time and spectral-time mapping of ventricular ECG complex were performed in patients additionally to routine examination.

Results. Reduction of ventricular rhythm disorders rate was detected during therapy with extended-release theophylline or salmeterol/fluticasone in patients with moderate and severe COPD. This effect was more significant for salmeterol/fluticasone treatment. Treatment with extended-release theophylline led to increase of a number of ventricular extra systoles in patients with severe COPD. Salmeterol/fluticasone treatment did not influence number of ventricular extrasystoles. Broncholytic therapy had positive influence on processes of ventricular depolarization. It was shown by high resolution ECG indicators improvement and by late ventricular potential rate reduction.

Conclusion. Salmeterol/fluticasone combination is more reasonable than extended-release theophylline for broncholytic therapy in patients with severe COPD and ventricular rhythm disorders.

About the Authors

Kh. Kh. Shugushev
Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Tchernyshevsky 173, Nalchik, 360004


M. V. Gurizheva
Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Tchernyshevsky 173, Nalchik, 360004


V. M. Vasilenko
Kabardino-Balkarian State University named after H. M. Berbekov
Russian Federation
Tchernyshevsky 173, Nalchik, 360004


References

1. Чучалин А.Г., редактор. Хроническая обструктивная болезнь легких. Клинические рекомендации. М.: АТМОСФЕРА; 2006.

2. Явелов И.С. О безопасности длительнодействующих бета2-агонистов. Взгляд кардиолога. Пульмонология 2007;(1):112-6.

3. Engström G., Wollmer P., Hedblad B. et al. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a stady from «men born in 1914», Malmo, Sweden. Circulation 2001;103(25):3086-91.

4. Rutten F.H., Moons K.G., Gramer M.J. et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331(7529):1379.

5. Айсанов З.Р., Кокосов А.Н., Овчаренко С.И., и др. Хронические обструктивные болезни легких. Федеральная программа. РМЖ 2001;9(1):9-34.

6. Global initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Man￾agement, and Prevention of Chronic Obstructive Lung Disease. NHLBI/WHO workshop report. National Heart, Lung, and Blood Institute, update 2008. Available on http://www.goldcopd.com/download.asp?intId=504

7. Иванов Г.Г., Грачев С.В., Сыркин А.Л., редакторы. Электрокардиография высокого разрешения. М.: Триада-Х; 2003.

8. Бойцов С.А., Гришаев С.Л., Тищенко О.Л. и др. Новый метод описания результатов спектрально-временного картирования ЭКГ ВР и оценка его диагностической эффективности. Вестник аритмологии 1999;(14):25-9.

9. Лышова О.В., Проворотов В.М., Гречкин В.И. Нарушение сердечного ритма у больных хронической обструктивной болезнью легких. Тезисы докладов 13 Национального конгресса по болезням органов дыхания. М.: 2003. С.333.

10. Ануфриев И.И., Кустова Е.В. Особенности развития дисфункции миокарда у больных ХОБЛ. Тезисы докладов 13 Национального конгресса по болезням органов дыхания. М.: 2003. С.321.

11. Иванов Г.Г., Ковтун В.В., Фоломеев В.Н., Востриков В.А. Анализ поздних потенциалов желудочков сердца у больных с дыхательной недостаточностью. Анестезиология и реанимация 1991;(6):46-8.

12. Латфуллин И.А., Ким З.Ф., Тептин Г.М. Поздние потенциалы желудочков. Вестник аритмологии 2008;(53):44-55.

13. Tukek T., Yildiz P., Tuzcu V. et al. Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease. Int J Cardiol 2003;88(2-3):199- 206.

14. Yildiz P., Tukek T., Akkaya V. et al. Ventricular arrhythmias in patients with COLD are associated with QT dispersion. Chest 2002;122(6):2055-61.

15. Цой А.Н., Кепанова Е.Б., Архипов В.В. Клиническая эффективность серетида у больных ХОБЛ по материалам исследования TRISTAN. Пульмонология 2004;(4):122-4.


Review

For citations:


Shugushev Kh.Kh., Gurizheva M.V., Vasilenko V.M. INFLUENCE OF BRONCHOLYTIC THERAPY ON VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Rational Pharmacotherapy in Cardiology. 2009;5(5):63-66. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-5-63-66

Views: 742


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)